A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...

The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...

FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...

New research highlights nasal spray drug’s potential to counter Alzheimer’s by targeting brain enzyme dysfunction.

Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter publish ...

Decongestants can come in the form of tablets or nasal sprays, and are popular during cold and flu season. (Getty Images) ...

Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored ...

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as ...

A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...